Loading events...
Advancing Next-Generation Delivery, Gene Editing, & Assay Development to Optimize the Clinical Impact, Risk–Benefit Profile, & Scalability of Gene Therapies Gene therapy is entering a defining new chapter. After a period of challenge and recalibration, the field is regaining momentum, driven by teams who remain steadfast in their belief that this science can transform lives. Confidence is returning, with significant investments and acquisitions signalling a renewed commitment to overcoming barr
Sunday, February 1, 2026 - Tuesday, February 3, 2026
Boston, USA
100 expected
Advancing Next-Generation Delivery, Gene Editing, & Assay Development to Optimize the Clinical Impact, Risk–Benefit Profile, & Scalability of Gene Therapies Gene therapy is entering a defining new chapter. After a period of challenge and recalibration, the field is regaining momentum, driven by teams who remain steadfast in their belief that this science can transform lives. Confidence is returning, with significant investments and acquisitions signalling a renewed commitment to overcoming barr
Get curated B2B events, AI-powered insights, and industry trends delivered to your inbox